Wednesday, February 27, 2019

A novel long non-coding RNA-KAT7 is low expressed in colorectal cancer and acts as a tumor suppressor | Cancer Cell International | Full Text

A novel long non-coding RNA-KAT7 is low expressed in colorectal cancer and acts as a tumor suppressor | Cancer Cell International | Full Text

Cancer Cell International

A novel long non-coding RNA-KAT7 is low expressed in colorectal cancer and acts as a tumor suppressor

  • ,
  • ,
  • ,
  • ,
  • ,
  • ,
  • ,
  •  and
  • Email author
Contributed equally
Cancer Cell International201919:40
  • Received: 8 December 2018
  • Accepted: 15 February 2019
  • Published: 

Abstract

Background

The abnormal expression of many long non-coding RNAs (lncRNAs) has been reported in the progression of various tumors. However, the potential biological roles and regulatory mechanisms of long non-coding RNAs in the development of colorectal cancer (CRC) have not yet been fully elucidated. Therefore, it is crucial to identify that lncRNAs can be used for the clinical prevention and treatment of CRC.

Methods

In our previous work, we identificated a novel lncRNA, lncRNA-KAT7, and found that the expression of lncRNA-KAT7 in CRC tissues was significantly lower than that in matched normal intestinal tissues, and the expression in CRC cell lines was lower than that of normal intestinal epithelial cells (P < 0.05). Besides, the expression of lncRNA-KAT7 is negative associated with age, tumor size, tumor differentiation, lymph node metastasis of CRC patients. The potential biological effects and molecular mechanisms of lncRNA-KAT7 in CRC were evaluated using a series of CCK-8 assay, clone formation assay, EdU proliferation assay, scratch determination, transwell determination, western blot analysis, and nude subcutaneous tumorigenesis model construction cell and animal experiments.

Results

The expression of lncRNA-KAT7 in CRC tissues was lower than that in matched normal tissues and normal intestinal epithelial cells (P < 0.05). Decreased expression of lncRNA-KAT7 is associated with clinicopathological features of poor CRC patients. In vitro experiments showed that up-regulation of lncRNA-KAT7 expression in CRC cells inhibited cell proliferation and migration. In vivo animal experiments showed that the lncRNA-KAT7 also inhibited tumor growth. Western blot analysis showed that the expression of lncRNA-KAT7 was up-regulated in HCT116 cells, the expression of E-cadherin increased, and the expression of Vimentin, MMP-2 and β-catenin protein was down-regulated so did the phosphorylation NF-κB P65. The results confirm that the expression of lncRAN-KAT7 can inhibit the malignant phenotype of CRC cells.

Conclusions

Up to now, as a novel lncRNA, lncRNA-KAT7 has not any relevant research and reports. The results confirm that the expression of lncRNA-KAT7 can inhibit the malignant phenotype of CRC cells. And it can be used as a new diagnostic biomarker and therapeutic target for the development of CRC.

Keywords

  • lncRNA-KAT7
  • Colorectal cancer
  • Proliferation
  • Invasion
  • Migration
  • Tumor suppressor

No comments:

Post a Comment